Found 21 hits of Enzyme Inhibition Constant Data Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50436459
(CHEMBL2396661)Show SMILES Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Similars
| PDB Article PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of P110alpha (unknown origin) by Kinase-Glo assay |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50113952
(CHEMBL3605177)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc2COc3cnc(cc3-c2s1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H22F3N5O3S/c1-9-4-5-28(14(9)16(24)29)18(30)27-17-26-11-8-31-12-7-25-13(6-10(12)15(11)32-17)19(2,3)20(21,22)23/h6-7,9,14H,4-5,8H2,1-3H3,(H2,24,29)(H,26,27,30)/t9-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 5 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of P110alpha (unknown origin) by Kinase-Glo assay |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50113952
(CHEMBL3605177)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc2COc3cnc(cc3-c2s1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H22F3N5O3S/c1-9-4-5-28(14(9)16(24)29)18(30)27-17-26-11-8-31-12-7-25-13(6-10(12)15(11)32-17)19(2,3)20(21,22)23/h6-7,9,14H,4-5,8H2,1-3H3,(H2,24,29)(H,26,27,30)/t9-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of myristoylated human P110alpha expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analy... |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50113951
(CHEMBL3605178)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc(C)c(s1)-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H24F3N5O2S/c1-10-6-8-28(14(10)16(24)29)18(30)27-17-26-11(2)15(31-17)12-5-7-25-13(9-12)19(3,4)20(21,22)23/h5,7,9-10,14H,6,8H2,1-4H3,(H2,24,29)(H,26,27,30)/t10-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of myristoylated human P110alpha expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analy... |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50113951
(CHEMBL3605178)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc(C)c(s1)-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H24F3N5O2S/c1-10-6-8-28(14(10)16(24)29)18(30)27-17-26-11(2)15(31-17)12-5-7-25-13(9-12)19(3,4)20(21,22)23/h5,7,9-10,14H,6,8H2,1-4H3,(H2,24,29)(H,26,27,30)/t10-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 19 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of P110alpha (unknown origin) by Kinase-Glo assay |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM50436459
(CHEMBL2396661)Show SMILES Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Similars
| PDB Article PubMed
| n/a | n/a | 74 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of myristoylated human P110alpha expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analy... |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | 3D Structure (crystal) |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50113952
(CHEMBL3605177)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc2COc3cnc(cc3-c2s1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H22F3N5O3S/c1-9-4-5-28(14(9)16(24)29)18(30)27-17-26-11-8-31-12-7-25-13(6-10(12)15(11)32-17)19(2,3)20(21,22)23/h6-7,9,14H,4-5,8H2,1-3H3,(H2,24,29)(H,26,27,30)/t9-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of P110gamma (unknown origin) using PI or PIP2:PS as substrate measured for 15 to 60 mins by TR-FRET analysis |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50113952
(CHEMBL3605177)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc2COc3cnc(cc3-c2s1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H22F3N5O3S/c1-9-4-5-28(14(9)16(24)29)18(30)27-17-26-11-8-31-12-7-25-13(6-10(12)15(11)32-17)19(2,3)20(21,22)23/h6-7,9,14H,4-5,8H2,1-3H3,(H2,24,29)(H,26,27,30)/t9-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 220 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of P110delta (unknown origin) using PI or PIP2:PS as substrate measured for 15 to 60 mins by TR-FRET analysis |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50113951
(CHEMBL3605178)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc(C)c(s1)-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H24F3N5O2S/c1-10-6-8-28(14(10)16(24)29)18(30)27-17-26-11(2)15(31-17)12-5-7-25-13(9-12)19(3,4)20(21,22)23/h5,7,9-10,14H,6,8H2,1-4H3,(H2,24,29)(H,26,27,30)/t10-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 230 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of P110gamma (unknown origin) using PI or PIP2:PS as substrate measured for 15 to 60 mins by TR-FRET analysis |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
(Homo sapiens (Human)) | BDBM50436459
(CHEMBL2396661)Show SMILES Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 250 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of P110gamma (unknown origin) using PI or PIP2:PS as substrate measured for 15 to 60 mins by TR-FRET analysis |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50436459
(CHEMBL2396661)Show SMILES Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 290 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of P110delta (unknown origin) using PI or PIP2:PS as substrate measured for 15 to 60 mins by TR-FRET analysis |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50113951
(CHEMBL3605178)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc(C)c(s1)-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H24F3N5O2S/c1-10-6-8-28(14(10)16(24)29)18(30)27-17-26-11(2)15(31-17)12-5-7-25-13(9-12)19(3,4)20(21,22)23/h5,7,9-10,14H,6,8H2,1-4H3,(H2,24,29)(H,26,27,30)/t10-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 390 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of P110delta (unknown origin) using PI or PIP2:PS as substrate measured for 15 to 60 mins by TR-FRET analysis |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50113952
(CHEMBL3605177)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc2COc3cnc(cc3-c2s1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H22F3N5O3S/c1-9-4-5-28(14(9)16(24)29)18(30)27-17-26-11-8-31-12-7-25-13(6-10(12)15(11)32-17)19(2,3)20(21,22)23/h6-7,9,14H,4-5,8H2,1-3H3,(H2,24,29)(H,26,27,30)/t9-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 540 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of myristoylated human P110delta expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analy... |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50113951
(CHEMBL3605178)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc(C)c(s1)-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H24F3N5O2S/c1-10-6-8-28(14(10)16(24)29)18(30)27-17-26-11(2)15(31-17)12-5-7-25-13(9-12)19(3,4)20(21,22)23/h5,7,9-10,14H,6,8H2,1-4H3,(H2,24,29)(H,26,27,30)/t10-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 616 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of myristoylated human P110delta expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analy... |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50113952
(CHEMBL3605177)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc2COc3cnc(cc3-c2s1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H22F3N5O3S/c1-9-4-5-28(14(9)16(24)29)18(30)27-17-26-11-8-31-12-7-25-13(6-10(12)15(11)32-17)19(2,3)20(21,22)23/h6-7,9,14H,4-5,8H2,1-3H3,(H2,24,29)(H,26,27,30)/t9-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 670 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of P110beta (unknown origin) by Kinase-Glo assay |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50113951
(CHEMBL3605178)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc(C)c(s1)-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H24F3N5O2S/c1-10-6-8-28(14(10)16(24)29)18(30)27-17-26-11(2)15(31-17)12-5-7-25-13(9-12)19(3,4)20(21,22)23/h5,7,9-10,14H,6,8H2,1-4H3,(H2,24,29)(H,26,27,30)/t10-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.04E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of P110beta (unknown origin) by Kinase-Glo assay |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50113952
(CHEMBL3605177)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc2COc3cnc(cc3-c2s1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H22F3N5O3S/c1-9-4-5-28(14(9)16(24)29)18(30)27-17-26-11-8-31-12-7-25-13(6-10(12)15(11)32-17)19(2,3)20(21,22)23/h6-7,9,14H,4-5,8H2,1-3H3,(H2,24,29)(H,26,27,30)/t9-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of myristoylated human P110beta expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analys... |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50436459
(CHEMBL2396661)Show SMILES Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of P110beta (unknown origin) by Kinase-Glo assay |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM50436459
(CHEMBL2396661)Show SMILES Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of myristoylated human P110delta expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analy... |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50113951
(CHEMBL3605178)Show SMILES C[C@@H]1CCN([C@@H]1C(N)=O)C(=O)Nc1nc(C)c(s1)-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C20H24F3N5O2S/c1-10-6-8-28(14(10)16(24)29)18(30)27-17-26-11(2)15(31-17)12-5-7-25-13(9-12)19(3,4)20(21,22)23/h5,7,9-10,14H,6,8H2,1-4H3,(H2,24,29)(H,26,27,30)/t10-,14+/m1/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of myristoylated human P110beta expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analys... |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform
(Homo sapiens (Human)) | BDBM50436459
(CHEMBL2396661)Show SMILES Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(c1)C(C)(C)C(F)(F)F |r| Show InChI InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| Purchase
CHEMBL MCE MMDB PC cid PC sid PDB UniChem
Similars
| Article PubMed
| n/a | n/a | 2.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Institutes for BioMedical Research
Curated by ChEMBL
| Assay Description Inhibition of myristoylated human P110beta expressed in Rat1 cells assessed as inhibition of Akt phosphorylation at Serine 473 by Western blot analys... |
Bioorg Med Chem Lett 25: 3582-4 (2015)
Article DOI: 10.1016/j.bmcl.2015.06.077 BindingDB Entry DOI: 10.7270/Q2G73GJG |
More data for this Ligand-Target Pair | |